vs
Side-by-side financial comparison of Axsome Therapeutics, Inc. (AXSM) and CATHAY GENERAL BANCORP (CATY). Click either name above to swap in a different company.
CATHAY GENERAL BANCORP is the larger business by last-quarter revenue ($222.8M vs $196.0M, roughly 1.1× Axsome Therapeutics, Inc.). CATHAY GENERAL BANCORP runs the higher net margin — 653.4% vs -14.6%, a 668.0% gap on every dollar of revenue. On growth, Axsome Therapeutics, Inc. posted the faster year-over-year revenue change (65.0% vs 19.5%). CATHAY GENERAL BANCORP produced more free cash flow last quarter ($363.7M vs $-18.7M). Over the past eight quarters, Axsome Therapeutics, Inc.'s revenue compounded faster (61.7% CAGR vs 12.8%).
Jazz Pharmaceuticals plc is a global biopharmaceutical company with a focus on oncology and neuroscience. It was founded in 2003 in California, United States and is now headquartered in Dublin, Ireland.
Cathay General Bancorp is a U.S.-headquartered bank holding company that operates Cathay Bank, offering full-spectrum commercial and personal banking services. It primarily serves Asian American communities and small-to-medium enterprises across major U.S. states including California, New York and Texas, as well as select Asian markets, with products covering deposits, loans, and wealth management solutions.
AXSM vs CATY — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $196.0M | $222.8M |
| Net Profit | $-28.6M | $90.5M |
| Gross Margin | — | — |
| Operating Margin | -13.8% | 50.9% |
| Net Margin | -14.6% | 653.4% |
| Revenue YoY | 65.0% | 19.5% |
| Net Profit YoY | 61.9% | 12.9% |
| EPS (diluted) | $-0.55 | $1.33 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $196.0M | $222.8M | ||
| Q3 25 | $171.0M | $210.6M | ||
| Q2 25 | $150.0M | $196.6M | ||
| Q1 25 | $121.5M | $187.8M | ||
| Q4 24 | $118.8M | $186.5M | ||
| Q3 24 | $104.8M | $189.5M | ||
| Q2 24 | $87.2M | $178.5M | ||
| Q1 24 | $75.0M | $175.2M |
| Q4 25 | $-28.6M | $90.5M | ||
| Q3 25 | $-47.2M | $77.7M | ||
| Q2 25 | $-48.0M | $77.5M | ||
| Q1 25 | $-59.4M | $69.5M | ||
| Q4 24 | $-74.9M | $80.2M | ||
| Q3 24 | $-64.6M | $67.5M | ||
| Q2 24 | $-79.3M | $66.8M | ||
| Q1 24 | $-68.4M | $71.4M |
| Q4 25 | -13.8% | 50.9% | ||
| Q3 25 | -27.0% | 44.5% | ||
| Q2 25 | -24.5% | 49.0% | ||
| Q1 25 | -46.9% | 46.1% | ||
| Q4 24 | -61.1% | 46.5% | ||
| Q3 24 | -59.8% | 41.2% | ||
| Q2 24 | -89.5% | 40.7% | ||
| Q1 24 | -89.7% | 45.7% |
| Q4 25 | -14.6% | 653.4% | ||
| Q3 25 | -27.6% | 36.9% | ||
| Q2 25 | -32.0% | 39.4% | ||
| Q1 25 | -48.9% | 37.0% | ||
| Q4 24 | -63.1% | 587.9% | ||
| Q3 24 | -61.7% | 35.6% | ||
| Q2 24 | -91.0% | 37.4% | ||
| Q1 24 | -91.1% | 40.8% |
| Q4 25 | $-0.55 | $1.33 | ||
| Q3 25 | $-0.94 | $1.13 | ||
| Q2 25 | $-0.97 | $1.10 | ||
| Q1 25 | $-1.22 | $0.98 | ||
| Q4 24 | $-1.54 | $1.11 | ||
| Q3 24 | $-1.34 | $0.94 | ||
| Q2 24 | $-1.67 | $0.92 | ||
| Q1 24 | $-1.44 | $0.98 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $322.9M | — |
| Total DebtLower is stronger | — | $119.1M |
| Stockholders' EquityBook value | $88.3M | $2.9B |
| Total Assets | $689.8M | $24.2B |
| Debt / EquityLower = less leverage | — | 0.04× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $322.9M | — | ||
| Q3 25 | $325.3M | — | ||
| Q2 25 | $303.0M | — | ||
| Q1 25 | $300.9M | — | ||
| Q4 24 | $315.4M | — | ||
| Q3 24 | $327.3M | — | ||
| Q2 24 | $315.7M | — | ||
| Q1 24 | $331.4M | — |
| Q4 25 | — | $119.1M | ||
| Q3 25 | — | $119.1M | ||
| Q2 25 | — | $119.1M | ||
| Q1 25 | — | $119.1M | ||
| Q4 24 | — | $119.1M | ||
| Q3 24 | — | $119.1M | ||
| Q2 24 | — | $119.1M | ||
| Q1 24 | — | $119.1M |
| Q4 25 | $88.3M | $2.9B | ||
| Q3 25 | $73.7M | $2.9B | ||
| Q2 25 | $73.1M | $2.9B | ||
| Q1 25 | $53.2M | $2.9B | ||
| Q4 24 | $57.0M | $2.8B | ||
| Q3 24 | $92.9M | $2.8B | ||
| Q2 24 | $102.9M | $2.8B | ||
| Q1 24 | $144.0M | $2.8B |
| Q4 25 | $689.8M | $24.2B | ||
| Q3 25 | $669.3M | $24.1B | ||
| Q2 25 | $639.8M | $23.7B | ||
| Q1 25 | $596.7M | $23.2B | ||
| Q4 24 | $568.5M | $23.1B | ||
| Q3 24 | $561.5M | $23.3B | ||
| Q2 24 | $548.2M | $23.2B | ||
| Q1 24 | $545.7M | $23.4B |
| Q4 25 | — | 0.04× | ||
| Q3 25 | — | 0.04× | ||
| Q2 25 | — | 0.04× | ||
| Q1 25 | — | 0.04× | ||
| Q4 24 | — | 0.04× | ||
| Q3 24 | — | 0.04× | ||
| Q2 24 | — | 0.04× | ||
| Q1 24 | — | 0.04× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-18.7M | $368.6M |
| Free Cash FlowOCF − Capex | $-18.7M | $363.7M |
| FCF MarginFCF / Revenue | -9.6% | 163.2% |
| Capex IntensityCapex / Revenue | 0.0% | 2.2% |
| Cash ConversionOCF / Net Profit | — | 4.07× |
| TTM Free Cash FlowTrailing 4 quarters | $-93.9M | $672.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-18.7M | $368.6M | ||
| Q3 25 | $1.0M | $150.6M | ||
| Q2 25 | $-32.4M | $64.0M | ||
| Q1 25 | $-43.4M | $99.0M | ||
| Q4 24 | $-26.2M | $329.2M | ||
| Q3 24 | $-18.6M | $81.2M | ||
| Q2 24 | $-30.1M | $72.9M | ||
| Q1 24 | $-53.5M | $88.2M |
| Q4 25 | $-18.7M | $363.7M | ||
| Q3 25 | $988.0K | $150.1M | ||
| Q2 25 | $-32.4M | $62.7M | ||
| Q1 25 | $-43.7M | $96.3M | ||
| Q4 24 | $-26.2M | $325.5M | ||
| Q3 24 | $-18.7M | $80.0M | ||
| Q2 24 | $-30.2M | $72.4M | ||
| Q1 24 | $-53.6M | $87.3M |
| Q4 25 | -9.6% | 163.2% | ||
| Q3 25 | 0.6% | 71.3% | ||
| Q2 25 | -21.6% | 31.9% | ||
| Q1 25 | -36.0% | 51.2% | ||
| Q4 24 | -22.1% | 174.6% | ||
| Q3 24 | -17.9% | 42.2% | ||
| Q2 24 | -34.6% | 40.5% | ||
| Q1 24 | -71.4% | 49.8% |
| Q4 25 | 0.0% | 2.2% | ||
| Q3 25 | 0.0% | 0.2% | ||
| Q2 25 | 0.0% | 0.6% | ||
| Q1 25 | 0.3% | 1.4% | ||
| Q4 24 | 0.0% | 1.9% | ||
| Q3 24 | 0.1% | 0.6% | ||
| Q2 24 | 0.1% | 0.3% | ||
| Q1 24 | 0.1% | 0.5% |
| Q4 25 | — | 4.07× | ||
| Q3 25 | — | 1.94× | ||
| Q2 25 | — | 0.83× | ||
| Q1 25 | — | 1.42× | ||
| Q4 24 | — | 4.10× | ||
| Q3 24 | — | 1.20× | ||
| Q2 24 | — | 1.09× | ||
| Q1 24 | — | 1.23× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
